Biomarkers for Use in Monitoring Responses of Nasopharyngeal Carcinoma Cells to Ionizing Radiation

Sensors

Wei Gao¹  John Zenghong Li¹  Wai Kuen Ho¹  Jimmy Yuwai Chan¹ 

[1] Department of Surgery, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China;

关键词: nasopharyngeal carcinoma;    radiotherapy;    ionizing radiation;    biomarkers;   

DOI  :  10.3390/s120708832

来源: mdpi

【 摘 要 】

Nasopharyngeal carcinoma (NPC) is a common head and neck cancer. The incidence rate is higher in southern China and Southeast Asia in comparison with the Western countries. Radiotherapy is the standard treatment of NPC as the cancer cells are sensitive to ionizing radiation. Radiation treatment has good local control to patients with early NPC. It is essential to monitor the response of the NPC cells to radiation treatment in advance in order to select suitable treatment choice for the patients. This review aims to discuss the potential use of biomarkers in monitoring the responsiveness of NPC cells to radiation treatment.

【 授权许可】

CC BY   
© 2012 by the authors; licensee MDPI, Basel, Switzerland.